| http://www.w3.org/ns/prov#value | - ???Clearly, pay-for-delay deal-making is an obstacle to getting cheaper prescription drugs on the market,??? Grassley said. ???These anti-competitive patent settlements between brand and generic drug companies hurt consumers??? access to affordable medications, and they hurt taxpayers who pay for prescription drugs under both Medicare and Medicaid.
|
